Market cap
₹7,998 Cr
Recently Viewed
Clear AllNSE: SUDEEPPHRM | BSE: 544619
₹707.55
₹14.75
(2.13%)
As on 30-Apr-2026IST
Market cap
₹7,998 Cr
Revenue (TTM)
₹502 Cr
P/E Ratio
57.7
P/B Ratio
9.2
Div. Yield
0 %
Quality Score
0/0
Growth Score
0/0
Valuation Score
0/0
Momentum Score
0/0
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
₹139 Cr
ROE
32.8 %
ROCE
35.8 %
Industry P/E
37.83
EV/EBITDA
40.3
Debt to Equity
0.3
Book Value
₹50.5
EPS
₹14.3
Face value
1
Shares outstanding
112,948,625
CFO
₹98.87 Cr
EBITDA
₹650.12 Cr
Net Profit
₹469.12 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Sudeep Pharma
| 17.4 | 16.6 | 16.3 | -- | -- | -- | -- |
|
BSE Healthcare
| 2.7 | 6.8 | 7.9 | 5.7 | 24.7 | 13.8 | 11.1 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Sudeep Pharma
|
707.6 | 7,997.9 | 502.0 | 138.7 | -- | 32.8 | 57.7 | 9.2 |
| 1,038.2 | 12,733.9 | 2,512.3 | 543.7 | 28.3 | 19.3 | 23.4 | 4.0 | |
| 444.6 | 7,694.1 | 1,053.1 | 293.6 | 32.3 | 24.6 | 26.2 | 5.9 | |
| 1,142.0 | 11,927.8 | 1,158.7 | 309.6 | 31.9 | 17.3 | 38.2 | 6.3 | |
| 1,680.1 | 31,850.1 | 8,850.1 | 894.8 | 15.2 | 19.8 | 36.6 | 6.4 | |
| 363.6 | 3,963.6 | 159.3 | 47.8 | 39.0 | 18.6 | 82.9 | 14.3 | |
| 15,003.0 | 19,243.2 | 1,575.1 | 179.1 | 14.9 | 11.4 | 107.4 | 11.6 | |
| 2,295.0 | 3,799.8 | 707.5 | 115.2 | 17.8 | 19.4 | 33 | -- | |
| 899.2 | 4,138.8 | 588.5 | 102.9 | 22.1 | 12.7 | 40.7 | 4.9 | |
| 211.9 | 5,585.6 | 7.1 | -274.7 | -4,008.3 | -140.4 | -- | 8.4 |
--
Incorporated
1989
Chairman
Sujit Jaysukh Bhayani
Managing Director
Sujit Jaysukh Bhayani
Headquarters
Vadodara, Gujarat
Website
Looking for more details about Sudeep Pharma Ltd’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Announcements
View AnnouncementsUn-Audited Financial Results As On 31.12.2025
06-Feb-2026No News & Announcements are available.
The share price of Sudeep Pharma Ltd is ₹707.55 (NSE) and ₹708.10 (BSE) as of 30-Apr-2026 IST. Sudeep Pharma Ltd has given a return of --% in the last 1 years.
The P/E ratio of Sudeep Pharma Ltd is 57.67 times as on 30-Apr-2026, a 52 premium to its peers’ median range of 37.83 times.
The P/B ratio of Sudeep Pharma Ltd is 9.21 times as on 30-Apr-2026, a 127 premium to its peers’ median range of 4.05 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
0.00
|
|
2024
|
0.00
|
0.00
|
|
2023
|
0.00
|
0.00
|
|
2022
|
0.00
|
0.00
|
|
2021
|
0.00
|
0.00
|
The 52-week high and low of Sudeep Pharma Ltd are Rs 795.00 and Rs 524.05 as of 30-Apr-2026.
Sudeep Pharma Ltd has a market capitalisation of ₹ 7,998 Cr as on 30-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Sudeep Pharma Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.